{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T15:37:28Z","timestamp":1781710648538,"version":"3.54.5"},"reference-count":33,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T00:00:00Z","timestamp":1728432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Surgery often leads to bleeding associated with hypofibrinogenemia. Supplementation with fibrinogen concentrate appears to be effective and safe, although findings from studies are inconsistent. The primary aim of this study was to assess the safety of fibrinogen concentrate during the perioperative period. Methods: This single-centre, prospective, observational study included adult patients undergoing scheduled or emergency surgery related to bleeding coagulopathy and the administration of fibrinogen concentrate. Patients were followed until their discharge from the institution. Comprehensive data were collected, including age, sex, type of surgery, associated comorbidities, anticoagulant and\/or anti-aggregating therapy, and the number of blood transfusions. Laboratory data on plasma fibrinogen concentration, haemoglobin, and platelet count before and after surgery were also collected. The primary outcomes were the mortality rate at discharge and any reported thrombotic or thromboembolic events, including deep vein thrombosis, pulmonary embolism, and myocardial infarction. Results: The study included 91 adult patients who had undergone surgery, with 29 surgeries (32%) conducted in an emergency setting. The mean age was 59.2 years, and 53.8% were male. Major bleeding occurred in 29 cases, mainly in older males and those on anticoagulant therapy. The pre-operative fibrinogen level averaged 161 mg\/dL, and the average dosage of fibrinogen concentrate administered was 2.7 g. Eight patients died (8.8%), mostly due to septic or cardiogenic shock, with deaths being more frequent in emergency settings. Thromboembolic events occurred in eight patients, none of whom died. No additional adverse events directly related to the administration of fibrinogen concentrate were reported. Conclusions: Our findings suggest a favourable safety profile for fibrinogen concentrate in surgical patients, as evidenced by a low incidence of deaths and thromboembolic events, which were primarily attributed to other factors. Future research should strive to increase statistical robustness to further illuminate clinically significant patient safety measures.<\/jats:p>","DOI":"10.3390\/jcm13196018","type":"journal-article","created":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T12:22:48Z","timestamp":1728476568000},"page":"6018","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Safety of Fibrinogen Concentrate for Correcting Perioperative Bleeding-Associated Hypofibrinogenemia in Adults: A Single-Center Experience"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7749-8690","authenticated-orcid":false,"given":"Manuela","family":"Gomes","sequence":"first","affiliation":[{"name":"Transfusion Medicine Department, Hemovida, Hospital da Luz Lisboa, Luz Sa\u00fade, 1500-650 Lisboa, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9933-4075","authenticated-orcid":false,"given":"Miguel","family":"\u00c2ngelo-Dias","sequence":"additional","affiliation":[{"name":"NOVA Medical School, Faculdade de Ci\u00eancias M\u00e9dicas, NMS, FCM, Universidade Nova de Lisboa, 1169-056 Lisboa, Portugal"},{"name":"CHRC, NOVA Medical School, Faculdade de Ci\u00eancias M\u00e9dicas, NMS, FCM, Universidade Nova de Lisboa, 1169-056 Lisboa, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0831-2741","authenticated-orcid":false,"given":"Jorge","family":"Lima","sequence":"additional","affiliation":[{"name":"NOVA Medical School, Faculdade de Ci\u00eancias M\u00e9dicas, NMS, FCM, Universidade Nova de Lisboa, 1169-056 Lisboa, Portugal"},{"name":"CHRC, NOVA Medical School, Faculdade de Ci\u00eancias M\u00e9dicas, NMS, FCM, Universidade Nova de Lisboa, 1169-056 Lisboa, Portugal"},{"name":"Department of Obstetrics and Gynecology, Hospital da Luz Lisboa, Luz Sa\u00fade, Avenida Lus\u00edada 100, 1500-650 Lisboa, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,10,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1258\/0004563042466884","article-title":"Plasma fibrinogen","volume":"41","author":"Lowe","year":"2004","journal-title":"Ann. Clin. Biochem."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2147\/JBM.S90693","article-title":"Acquired hypofibrinogenemia: Current perspectives","volume":"7","author":"Besser","year":"2016","journal-title":"J. Blood Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1055\/s-0032-1309287","article-title":"Fibrinogen as a hemostatic agent","volume":"38","author":"Larsen","year":"2012","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1213\/ANE.0b013e31822e1853","article-title":"Fibrinogen and hemostasis: A primary hemostatic target for the management of acquired bleeding","volume":"114","author":"Levy","year":"2012","journal-title":"Anesth. Analg."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1517\/14712590903193051","article-title":"Fibrinogen concentrate\u2014A potential universal hemostatic agent","volume":"9","author":"Ingerslev","year":"2009","journal-title":"Expert. Opin. Biol. Ther."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.medin.2016.01.003","article-title":"Clinical efficacy of fresh frozen plasma compared with coagulation factor concentrates for treating coagulopathy in patients with massive bleeding","volume":"40","year":"2016","journal-title":"Med. Intensiv."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1160\/TH14-06-0514","article-title":"Safety of fibrinogen concentrate: Analysis of more than 27 years of pharmacovigilance data","volume":"113","author":"Solomon","year":"2015","journal-title":"Thromb. Haemost."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/1076029615601494","article-title":"Over 50 Years of Fibrinogen Concentrate","volume":"22","author":"Hochleitner","year":"2016","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/EJA.0000000000001803","article-title":"Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care: Second update 2022","volume":"40","author":"Kietaibl","year":"2023","journal-title":"Eur. J. Anaesthesiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13054-023-04327-7","article-title":"The European guideline on management of major bleeding and coagulopathy following trauma: Sixth edition","volume":"27","author":"Rossaint","year":"2023","journal-title":"Crit. Care"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Gomes, M., Angelo-Dias, M., Duarte, G.S., Dias, S.S., Serra, S.S., and Lima, J. (2024). Safety of Fibrinogen Concentrate in Non-Trauma and Non-Obstetric Adult Patients during Perioperative Care: Systematic Review and Meta-Analysis. J. Clin. Med., 13.","DOI":"10.3390\/jcm13123482"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1053\/j.jvca.2016.04.015","article-title":"Efficacy and Safety of Fibrinogen Concentrate in Surgical Patients: A Meta-Analysis of Randomized Controlled Trials","volume":"30","author":"Fominskiy","year":"2016","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1399-6576.2011.02586.x","article-title":"Systematic review of the efficacy and safety of fibrinogen concentrate substitution in adults","volume":"56","author":"Warmuth","year":"2012","journal-title":"Acta Anaesthesiol. Scand."},{"key":"ref_14","first-page":"CD008864","article-title":"Fibrinogen concentrate in bleeding patients","volume":"2013","author":"Wikkelso","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1111\/trf.12431","article-title":"Fibrinogen as a therapeutic target for bleeding: A review of critical levels and replacement therapy","volume":"54","author":"Levy","year":"2014","journal-title":"Transfusion"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e002066","DOI":"10.1161\/JAHA.115.002066","article-title":"Randomized, double-blinded, placebo-controlled trial of fibrinogen concentrate supplementation after complex cardiac surgery","volume":"4","author":"Ranucci","year":"2015","journal-title":"J. Am. Heart Assoc."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"109782","DOI":"10.1016\/j.jclinane.2020.109782","article-title":"The effect of fibrinogen concentrate on postoperative blood loss: A systematic review and meta-analysis of randomized controlled trials","volume":"63","author":"Ng","year":"2020","journal-title":"J. Clin. Anesth."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1111\/ajt.13752","article-title":"Impact of Preemptive Fibrinogen Concentrate on Transfusion Requirements in Liver Transplantation: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial","volume":"16","author":"Sabate","year":"2016","journal-title":"Am. J. Transplant."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/jth.14665","article-title":"Efficacy of fibrinogen concentrate in major abdominal surgery\u2014A prospective, randomized, controlled study in cytoreductive surgery for pseudomyxoma peritonei","volume":"18","author":"Roy","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1001\/jama.2019.17312","article-title":"Effect of Fibrinogen Concentrate vs Cryoprecipitate on Blood Component Transfusion After Cardiac Surgery: The FIBRES Randomized Clinical Trial","volume":"322","author":"Callum","year":"2019","journal-title":"JAMA"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/bja\/aew169","article-title":"Randomized evaluation of fibrinogen vs placebo in complex cardiovascular surgery (REPLACE): A double-blind phase III study of haemostatic therapy","volume":"117","author":"Levy","year":"2016","journal-title":"Br. J. Anaesth."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/ALN.0b013e3182715d4d","article-title":"Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: A randomized, placebo-controlled trial","volume":"118","author":"Solomon","year":"2013","journal-title":"Anesthesiology"},{"key":"ref_23","first-page":"804","article-title":"Prophylactic administration of fibrinogen concentrate in perioperative period of total hip arthroplasty: A randomized clinical trial study","volume":"52","author":"Najafi","year":"2014","journal-title":"Acta Med. Iran."},{"key":"ref_24","unstructured":"Dire\u00e7\u00e3o Geral da Sa\u00fade (2024, August 05). Abordagem da Transfus\u00e3o Maci\u00e7a no Adulto. Recommendation nr. 011\/2013, Updated on 18 July 2017. Available online: https:\/\/normas.dgs.min-saude.pt\/2013\/07\/30\/abordagem-da-transfusao-macica-no-adulto\/."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1177\/1076029615584662","article-title":"Effects of Fibrinogen Concentrate on Thrombin Generation, Thromboelastometry Parameters, and Laboratory Coagulation Testing in a 24-Hour Porcine Trauma Model","volume":"22","author":"Zentai","year":"2016","journal-title":"Clin. Appl. Thromb. Hemost"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/ALN.0000000000000315","article-title":"Fibrinogen concentrate does not suppress endogenous fibrinogen synthesis in a 24-hour porcine trauma model","volume":"121","author":"Zentai","year":"2014","journal-title":"Anesthesiology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13049-016-0221-8","article-title":"Fibrinogen levels in trauma patients during the first seven days after fibrinogen concentrate therapy: A retrospective study","volume":"24","author":"Schlimp","year":"2016","journal-title":"Scand. J. Trauma. Resusc. Emerg. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/1076029614559773","article-title":"Interventional Algorithms for the Control of Coagulopathic Bleeding in Surgical, Trauma, and Postpartum Settings: Recommendations From the Share Network Group","volume":"22","author":"Carvalho","year":"2016","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00423-023-03122-w","article-title":"The impact of anemia and blood transfusion on mortality after open abdominal surgery in the elderly","volume":"408","author":"Buhl","year":"2023","journal-title":"Langenbecks Arch. Surg."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1213\/ANE.0000000000004528","article-title":"Transfusion of Red Blood Cells, Fresh Frozen Plasma, or Platelets Is Associated With Mortality and Infection After Cardiac Surgery in a Dose-Dependent Manner","volume":"130","author":"Ming","year":"2020","journal-title":"Anesth. Analg."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1378\/chest.09-0252","article-title":"Complications of massive transfusion","volume":"137","author":"Sihler","year":"2010","journal-title":"Chest"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13017-023-00497-5","article-title":"Emergency administration of fibrinogen concentrate for haemorrhage: Systematic review and meta-analysis","volume":"18","author":"Itagaki","year":"2023","journal-title":"World J. Emerg. Surg."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1538-7836.2007.02297.x","article-title":"sThe decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage","volume":"5","author":"Charbit","year":"2007","journal-title":"J. Thromb. Haemost."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/19\/6018\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:09:57Z","timestamp":1760112597000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/19\/6018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,9]]},"references-count":33,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["jcm13196018"],"URL":"https:\/\/doi.org\/10.3390\/jcm13196018","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,9]]}}}